Archive ready

2025年3月期 第2四半期決算短信〔日本基準〕(連結)

https://www.cawachi.co.jp/wp/wp-content/uploads/ir-tan20241025.pdf
May 13, 2026 at 12:40 AM JSTThe archive page, viewer, and downloads use this saved version.
May 13, 2026 at 12:40 AM JST·www.cawachi.co.jp

The evidence pack includes HTML, screenshots, summaries, and metadata. It can be downloaded on Pro.

Saved PDF

2025年3月期 第2四半期決算短信〔日本基準〕(連結)

StartedMay 13, 2026 at 12:40 AM JST
File size0.23 MB
SHA-256ae23bc412cfb2b1136538698f24a3b5ffe3575a5fd9ca422f306a0c0bb797384
About this pageAI generated

This document is the financial results report for the second quarter (interim period) of the fiscal year ending March 2025 for Kawachi Pharmaceutical Co., Ltd., released on October 25, 2024. It covers the period from March 16, 2024, to September 15, 2024. The company reported a revenue of 147.376 billion yen, a 1.0% increase compared to the previous year. However, operating profit decreased by 6.5% to 4.107 billion yen, and both ordinary profit and net profit attributable to shareholders also saw declines. Despite efforts to enhance the business through new store openings and the establishment of pharmacies, the company faces challenges from increased competition and rising costs.